RCC1 and colorectal carcinoma: Following treatment with 5-FU or Doxo for 48 h, RCC1 knockdown markedly elevated γ-H2AX expression in both parental and drug-resistant CRC cells compared to drug treatment alone or control cells [Figure 6A and Supplementary Figure 8A].